MedPath
NMPA Approval

Dasatinib Tablets

国药准字H20244611

August 5, 2024

Drug Information

达沙替尼片

片剂

20mg

化学药品

August 5, 2024

Company Information

Applicant Company

海口市国家高新区南海大道273号-A

Manufacturing Company

海口市国家高新区南海大道273号-A

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达沙替尼片 - NMPA 批准文号 | MedPath